Terms: = Thyroid cancer AND TPM3, ENSG00000143549, 7170
17 results:
1. Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation.
Yan W; Zhang L; Lv F; Moccia M; Carlomagno F; Landry C; Santoro M; Gosselet F; Frett B; Li HY
Eur J Med Chem; 2021 Apr; 216():113265. PubMed ID: 33652352
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
[TBL] [Abstract] [Full Text] [Related]
3. U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors.
Papadopoulos KP; Borazanci E; Shaw AT; Katayama R; Shimizu Y; Zhu VW; Sun TY; Wakelee HA; Madison R; Schrock AB; Senaldi G; Nakao N; Hanzawa H; Tachibana M; Isoyama T; Nakamaru K; Deng C; Li M; Fan F; Zhao Q; Gao Y; Seto T; Jänne PA; Ou SI
Clin Cancer Res; 2020 Sep; 26(18):4785-4794. PubMed ID: 32591465
[TBL] [Abstract] [Full Text] [Related]
4. Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma.
van der Tuin K; Ventayol Garcia M; Corver WE; Khalifa MN; Ruano Neto D; Corssmit EPM; Hes FJ; Links TP; Smit JWA; Plantinga TS; Kapiteijn E; van Wezel T; Morreau H
Eur J Endocrinol; 2019 Apr; 180(4):235-241. PubMed ID: 30668525
[TBL] [Abstract] [Full Text] [Related]
5. Molecular characterization of cancers with NTRK gene fusions.
Gatalica Z; Xiu J; Swensen J; Vranic S
Mod Pathol; 2019 Jan; 32(1):147-153. PubMed ID: 30171197
[TBL] [Abstract] [Full Text] [Related]
6. Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma.
Ronsley R; Rassekh SR; Shen Y; Lee AF; Jantzen C; Halparin J; Albert C; Hawkins DS; Amed S; Rothstein R; Mungall AJ; Dix D; Blair G; Nadel H; Jones SJM; Laskin J; Marra MA; J Deyell R
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610391
[TBL] [Abstract] [Full Text] [Related]
7. Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma.
Créancier L; Vandenberghe I; Gomes B; Dejean C; Blanchet JC; Meilleroux J; Guimbaud R; Selves J; Kruczynski A
Cancer Lett; 2015 Aug; 365(1):107-11. PubMed ID: 26001971
[TBL] [Abstract] [Full Text] [Related]
8. Surgical treatment of 21 patients with spinal metastases of differentiated thyroid cancer.
Jiang L; Ouyang H; Liu X; Wei F; Wu F; Dang L; Liu Z
Chin Med J (Engl); 2014; 127(23):4092-6. PubMed ID: 25430455
[TBL] [Abstract] [Full Text] [Related]
9. Anchored multiplex PCR for targeted next-generation sequencing.
Zheng Z; Liebers M; Zhelyazkova B; Cao Y; Panditi D; Lynch KD; Chen J; Robinson HE; Shim HS; Chmielecki J; Pao W; Engelman JA; Iafrate AJ; Le LP
Nat Med; 2014 Dec; 20(12):1479-84. PubMed ID: 25384085
[TBL] [Abstract] [Full Text] [Related]
10. ALKoma: a cancer subtype with a shared target.
Mano H
Cancer Discov; 2012 Jun; 2(6):495-502. PubMed ID: 22614325
[TBL] [Abstract] [Full Text] [Related]
11. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
Greco A; Miranda C; Pierotti MA
Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
[TBL] [Abstract] [Full Text] [Related]
12. Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.
Brzeziańska E; Karbownik M; Migdalska-Sek M; Pastuszak-Lewandoska D; Włoch J; Lewiński A
Mutat Res; 2006 Jul; 599(1-2):26-35. PubMed ID: 16483615
[TBL] [Abstract] [Full Text] [Related]
13. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
[TBL] [Abstract] [Full Text] [Related]
14. NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident.
Beimfohr C; Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
Int J Cancer; 1999 Mar; 80(6):842-7. PubMed ID: 10074915
[TBL] [Abstract] [Full Text] [Related]
15. The influence of lymphangiography on the development of hypothyroidism in patients irradiated for Hodgkin's disease.
Fein DA; Hanlon AL; Corn BW; Curran WJ; Coia LR
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):13-8. PubMed ID: 8823254
[TBL] [Abstract] [Full Text] [Related]
16. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
[TBL] [Abstract] [Full Text] [Related]
17. A sequence analysis of the genomic regions involved in the rearrangements between tpm3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
[TBL] [Abstract] [Full Text] [Related]
